Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board MemberOXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Vivid Dx, a precision diagnostics company transforming pathogen detection and antimicrobial resistance (AMR) testing, today announced the appointment of John Sperzel as Chief Executive Officer and member of the Board of Directors, effective immediately.
